General Federal Contracts — March 19, 2026

$1.06B obligation (base+options $1.20B) for IT management, 82% outlayed, extends to 2028 potential.

$410M+ across Rapiscan, Smiths Detection, Leidos, Steampunk for detection/maintenance, long horizons to 2031-2033.

$450M+ in Oracle, Medline (x2), Deloitte for EHR/interfaces and prime vendor, options up to $1B+ total.

$415M+ Wisconsin Physicians, Charles River for MAC/ animal care, cost-plus structures to 2028-2029.

Firm fixed price in 70% of contracts risks cost overruns on long-term deliveries (e.g., Leidos SSA, Rapiscan portals to 2033).

Options unexercised in 12/18 contracts cap upside at $2B+ (e.g., Oracle VA $607M potential).

Non-competed awards (25%) like Leidos DHS/VA signal sole-source dependency, vulnerable to future rebids.

$1.5B+ in unexercised options across IT/health contracts (e.g., Salient HUD $150M+ upside).

Extensions to 2029-2033 in 40% of awards (DHS Rapiscan/Smiths, GSA Life Science).

High outlays (avg 45% obligated value executed) indicate low cancellation risk (e.g., Leidos SSA 82%).

65% of value ($1.9B) in NAICS 5415xx for civilian/defense IT (SSA, HUD, VA, DHS), full/open competition wins.

$500M+ in detection/maintenance/HR IT for CBP/USCIS, extending to 2031+.

$206M Medline prime vendor for 2026 months signals monthly cadence.

{"entity"=>"Leidos (LDOS)", "reason"=>"$1.13B across SSA/DHS (39% total value), $183M DHS options upside.", "trigger"=>"Q1 2026 option exercises or outlay acceleration"}

{"entity"=>"Oracle Health (ORCL)", "reason"=>"$176M VA EHRM obligated, $607M options in non-competed health IT.", "trigger"=>"Initial outlays post-$0 current; follow-on VA awards"}

{"entity"=>"Medline Industries", "reason"=>"Back-to-back $138M VA 2026 supply orders indicate recurring prime vendor.", "trigger"=>"March 2026 outlays confirming monthly pattern"}

{"entity"=>"DHS CBP IT/Equipment Awards", "reason"=>"$400M+ cluster across 5 firms, long extensions possible.", "trigger"=>"New FY2027 task orders or extensions to 2030+"}